|
C8ORF38 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.218400E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.562100E-03 |
| Normal-vs-Stage2 |
5.630500E-02 |
| Normal-vs-Stage3 |
5.358200E-01 |
| Normal-vs-Stage4 |
1.215000E-01 |
| Stage1-vs-Stage2 |
7.899600E-01 |
| Stage1-vs-Stage3 |
4.207400E-01 |
| Stage1-vs-Stage4 |
7.805400E-01 |
| Stage2-vs-Stage3 |
4.515400E-01 |
| Stage2-vs-Stage4 |
9.321800E-01 |
| Stage3-vs-Stage4 |
5.210200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.724480E-03 |
| Normal-vs-AfricanAmerican |
1.169600E-02 |
| Normal-vs-Asian |
7.450600E-01 |
| Caucasian-vs-AfricanAmerican |
9.209800E-01 |
| Caucasian-vs-Asian |
4.794400E-01 |
| AfricanAmerican-vs-Asian |
4.731600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.80310000000139E-05 |
| Normal-vs-Female |
4.957600E-01 |
| Male-vs-Female |
1.614370E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.275700E-03 |
| Normal-vs-Extreme_Weight |
1.144110E-02 |
| Normal-vs-Obese |
7.030400E-02 |
| Normal-vs-Extreme_Obese |
4.251600E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.928000E-01 |
| Normal_Weight-vs-Obese |
5.397400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.797800E-01 |
| Extreme_Weight-vs-Obese |
8.364000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.858200E-01 |
| Obese-vs-Extreme_Obese |
9.838400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.496600E-01 |
| Normal-vs-Age(41-60Yrs) |
7.388100E-04 |
| Normal-vs-Age(61-80Yrs) |
2.439700E-03 |
| Normal-vs-Age(81-100Yrs) |
1.629980E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.326620E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.638400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.168000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.108000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.650400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.383800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.243400E-04 |
| Normal-VS-Type2 PRCC |
9.281400E-03 |
| Normal-VS-KIRP CIMP |
8.915200E-01 |
| Normal-VS-Unclassified PRCC |
1.716110E-02 |
| Type1 PRCC-VS-Type2 PRCC |
7.975800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.225800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.960000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.336000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.845600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.706800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.708000E-02 |
| Normal-vs-N1 |
6.086400E-01 |
| Normal-vs-N2 |
3.795000E-01 |
| N0-vs-N1 |
2.723400E-01 |
| N0-vs-N2 |
8.759800E-01 |
| N1-vs-N2 |
4.485800E-01 |
|
|
